In Brief Many accounting leaders and observers have pointed out the need to expand the pipeline to the profession and ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

While physical attacks garner the most media attention, many more subtle antisemitic episodes have transpired at Pitt, some ...

The envy of every school choice state” is how a bill author teased legislation designed to bring school choice to the Lone ...